Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotheranostics in oncology: Making precision medicine possible.
Aboagye EO, Barwick TD, Haberkorn U. Aboagye EO, et al. Among authors: haberkorn u. CA Cancer J Clin. 2023 May-Jun;73(3):255-274. doi: 10.3322/caac.21768. Epub 2023 Jan 9. CA Cancer J Clin. 2023. PMID: 36622841 Free article. Review.
Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
Kratochwil C, Afshar-Oromieh A, Kopka K, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: haberkorn u. Semin Nucl Med. 2016 Sep;46(5):405-18. doi: 10.1053/j.semnuclmed.2016.04.004. Semin Nucl Med. 2016. PMID: 27553466 Review.
Radiolabeled prostate-specific membrane antigen small-molecule inhibitors.
Will L, Sonni I, Kopka K, Kratochwil C, Giesel FL, Haberkorn U. Will L, et al. Among authors: haberkorn u. Q J Nucl Med Mol Imaging. 2017 Jun;61(2):168-180. doi: 10.23736/S1824-4785.17.02977-6. Epub 2017 Feb 17. Q J Nucl Med Mol Imaging. 2017. PMID: 28217987 Free article. Review.
Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617.
Rathke H, Flechsig P, Mier W, Bronzel M, Mavriopoulou E, Hohenfellner M, Giesel FL, Haberkorn U, Kratochwil C. Rathke H, et al. Among authors: haberkorn u. J Nucl Med. 2019 Jun;60(6):806-811. doi: 10.2967/jnumed.118.218917. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389816 Free article.
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors.
Eder M, Pavan S, Bauder-Wüst U, van Rietschoten K, Baranski AC, Harrison H, Campbell S, Stace CL, Walker EH, Chen L, Bennett G, Mudd G, Schierbaum U, Leotta K, Haberkorn U, Kopka K, Teufel DP. Eder M, et al. Among authors: haberkorn u. Cancer Res. 2019 Feb 15;79(4):841-852. doi: 10.1158/0008-5472.CAN-18-0238. Epub 2019 Jan 3. Cancer Res. 2019. PMID: 30606721
Targeting of activated fibroblasts for imaging and therapy.
Lindner T, Loktev A, Giesel F, Kratochwil C, Altmann A, Haberkorn U. Lindner T, et al. Among authors: haberkorn u. EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16. doi: 10.1186/s41181-019-0069-0. EJNMMI Radiopharm Chem. 2019. PMID: 31659499 Free PMC article. Review.
Ligand engineering for theranostic applications.
Altmann A, Kratochwil C, Giesel F, Haberkorn U. Altmann A, et al. Among authors: haberkorn u. Curr Opin Chem Biol. 2021 Aug;63:145-151. doi: 10.1016/j.cbpa.2021.04.006. Epub 2021 May 17. Curr Opin Chem Biol. 2021. PMID: 34004409 Review.
578 results